616 Lower hydroxychloroquine blood levels are associated with higher Type 1 and 2 lupus activities
616 Lower hydroxychloroquine blood levels are associated with higher Type 1 and 2 lupus activities
About this item
Full title
Author / Creator
Publisher
London: Lupus Foundation of America
Journal title
Language
English
Formats
Publication information
Publisher
London: Lupus Foundation of America
Subjects
More information
Scope and Contents
Contents
BackgroundHydroxychloroquine (HCQ) is a mainstay of the initial and long-term treatment of systemic lupus erythematosus (SLE). HCQ blood levels can reflect adherence to the medication and have been correlated with SLE outcomes. However, little is known about the relationship between HCQ levels and SLE disease activity according to the Type 1 & 2 SL...
Alternative Titles
Full title
616 Lower hydroxychloroquine blood levels are associated with higher Type 1 and 2 lupus activities
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_53bcfc295a2547c18765d9939a2604b9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_53bcfc295a2547c18765d9939a2604b9
Other Identifiers
E-ISSN
2053-8790
DOI
10.1136/lupus-2022-lupus21century.37
